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BACKGROUND Transvenous temporary pacing is often used during
percutaneous coronary intervention (PCI) in patients undergoing
rotational atherectomy (RA) and is recommended for prophylactic use
in all cases involving the RCA. The placement of transvenous pacing
has cost implications as well as associated procedural risk, including
cardiac tamponade. Diamondback 360 Coronary Orbital Atherectomy
System (OAS) is a new device, used to treat de novo severely calciﬁed
coronary lesions in place of rotational atherectomy. The unique
mechanism of OAS may contribute to decreased incidence of brady-
cardia and heart block. It has not been previously reported in the
literature the incidence of temporary pacemaker placement during
OAS versus RA. The objective of this study is to identify if there is a
difference in placement of temporary transvenous pacemaker’s dur-
ing PCI with OAS compared with RA in a real world setting.
METHODS A multi-center retrospective analysis was completed on all
PCI cases that took place at St. Francis Hospital in NY and Metropol-
itan Heart and Vascular Institute in Minnesota, between January 1,
2012 and May 11, 2015, using either OAS or RA. We assessed the
number of cases in which temporary transvenous pacemakers were
placed. Statistical analysis was performed using the Chi-square test.
RESULTS There were 340 cases utilizing OAS, of which 12 cases had a
temporary pacemaker placed (3.5%), with 3 cases requiring activation
of pacing (0.9%) During orbital atherectomy, 8 of the pacemakers
were for RCA cases, 2 for LCX and 2 for LAD. There were 156 rotational
atherectomy cases, with 16 pacemakers placed (10.3%), with 5 cases
requiring activation of pacing (3.2%). 15 of the pacemakers placed with
RA were for RCA cases, and 1 was placed after a LAD perforation.
Temporary pacemakers were placed signiﬁcantly less for OAS cases as
compared with RA cases (p-value ¼ 0.003). Pacemaker activation
showed a strong trend of lower activation in the OAS arm (p-value ¼
0.057).
CONCLUSIONS This is the ﬁrst analysis that assessed the placement
of temporary pacing for OAS. In a real world setting, temporary
pacemakers were placed signiﬁcantly less for OAS cases as compared
to RA cases.
CATEGORIES CORONARY: Atherectomy (excluding thrombectomy)
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BACKGROUND True bifurcation lesion (TBL) is usually considered as
a risk factor of side branch (SB) occlusion when using single stent/
provisional 2-stent strategy to treat coronary bifurcation, although
there is still no adequate evidence. In the present study, we sought to
clarify this issue.
METHODS A total of 1170 consecutive patients with 1200 bifurcation
lesions undergoing one stent or provisional two stent techniques were
studied. The lesions were divided into non-TBL and TBL group
(Medina 1,1,1;1,0,1; and 0,1,1 were deﬁned as TBL). The incidence of SB
occlusion was analyzed. Multivariate logistic regression analysis was
performed to identify independent predictors of SB occlusion. We also
compared the diameter stenosis of TBL before and after pre-dilation
to analysis how pre-dilation affect the stenosis severity changing of
TBL. The TBL group was then divided into 3 subgroups according to
the median of the most severe diameter stenosis in MV and the me-
dian of diameter stenosis in SB after pre-dilatation: group I (diameter
stenosis of both MV and SB <median), group II (only diameter stenosis
of MV median or only diameter stenosis of SB median), and group
III (diameter stenosis of both MV and SB median). We compared the
incidence of SB occlusion in these 3 groups.RESULTS Although the incidence of SB occlusion in TBL group
(14.0%, 42 of 301 lesions) was higher than that in non-TBL group
(5.1%,46 of 899 lesions) (p<0.01), multivariate logistic regression
analysis showed that TBL was not independently predictive of SB
occlusion. High bifurcation angle, plaque located at the same side of
SB, MV TIMI ﬂow grade before stenting, pre-procedural diameter
stenosis of bifurcation core, diameter ratio between MV/SB, diameter
stenosis of SB before MV stenting were independent predictors of SB
occlusion. Pre-dilatation leads to signiﬁcantly decrease in the diam-
eter stenosis of proximal MV, SB, bifurcation core, and distal MV
(Table 1). After pre-dilation, the median of the most severe diameter
stenosis in MV was 52.7% and the median of diameter stenosis in SB
was 46.7%. As for the 3 subgroups of TBL, the incidence of SB
occlusion in group I(7.4%) were signiﬁcantly lower than group II
(13.0%) and group III (22.0%) (p¼0.025). There is no signiﬁcant
difference in the incidence of SB occlusion between group I (7.4%)
and non-TBL group (5.1%) (p¼0.53).
Table 1. Pre-dilatation leads to signiﬁcantly decrease in the diameter stenosis of TBLBaseline diameter
stenosis (%)Diameter stenosis after
pre-dilation (%) pProximal MV 58.15  26.13 43.17  18.93 p <0.01
Bifurcation core 46.25  28.02 32.83  21.02 p <0.01
Distal MV 55.46  23.89 42.70  18.00 p <0.01
The most severe diameter
stenosis of MV73.37  16.68 52.42  15.30 p <0.01Side branch 53.65  19.33 45.26  21.49 p <0.01Values presented as mean  standard deviation.
MV ¼ main vessel.
CONCLUSIONS TBL cannot be regarded as an independent predictor
of SB occlusion after MV stenting, unless considering the stenosis
severity changing after pre-dilation in MV and SB.
CATEGORIES CORONARY: Complications
KEYWORDS Bifurcation stenting, Side branch occlusion
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Impact of heterogeneity of human peripheral blood monocyte subsets on
collateral vessel development in patients with coronary chronic total
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BACKGROUND Monocytes, the most abundant immune cell type
found in atherosclerotic plaques, play important roles in inﬂamma-
tion, angiogenesis and tissue repair. Previous studies showed the as-
sociation between distinct monocyte subsets and cardiovascular
events. Here, we aimed to investigate the relationship between the
distinct human monocyte subsets and coronary collateral circulation
(CCC) in patients with chronic total occlusion (CTO).
METHODS A total of 184 patients with CTO were included. Peripheral
blood sampling was performed after the coronary angiography was
ﬁnished. Three monocyte subsets, classical CD14þþCD16-, interme-
diate CD14þþCD16þ, and nonclassical CD14þCD16þþ monocytes
were analyzed by ﬂow cytometry. Cohen-Rentrop method was used to
evaluate coronary collateral artery grading by two independent in-
vestigators. Disagreements were resolved via consensus. Patients
with grade 0-1 collateral development were regarded as the poor
collateral group, and patients with grade 2-3 collateral development
were regarded as the good collateral group. Clinical information were
obtained from a review of the patients’ charts.
RESULTS There was no difference between the two groups with
respect to traditional cardiovascular risk factors. CD14þþCD16-
monocyte subset (p¼0.006)counts were signiﬁcantly higher in pa-
tients with poor CCC, whereas neither the CD14þþCD16þ (p¼0.012)
nor the CD14þCD16þþ (p¼0.032)subset counts differed signiﬁcantly
between the two groups. In a multivariate logistic regression model,
the level of CD14þþCD16- monocytes remained an independent factor
for the presence of poor CCC (odds ratio 2.04, 95% conﬁdence inter-
val: 1.19-3.45; p¼0.01).
CONCLUSIONS CD14þþCD16- monocytes independently estimate the
development collateral vessel in patients with CTO, which indicates
that modulation CD14þþCD16- monocytes could be a potential target
for CTO treatment.
CATEGORIES CORONARY: Cell Therapy and Angiogenesis
KEYWORDS Chronic total occlusion, Coronary collateral artery
